Project Grant HT94252410081

Award Date 2/1/24
Completion Date 1/31/26
Dollars Obligated $300K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Tucson, AZ 85719, USA
Similar Awards
The University of Arizona, through its Arizona Board of Regents, was awarded a $687,884 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "TARGETING PROLACTIN FOR PREVENTION OF FEMALE-SELECTIVE NOCICEPTOR SENSITIZATION FOR TREATMENT OF FEMALE-PREDOMINANT PAIN SYNDROMES". This 4-year research project, with a start date of September 1, 2023, aims to transform healthcare for Service Members and the...
The University of Arizona was awarded a $1,791,407 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "Targeting Drug Resistance in the Bone Microenvironment Using a Novel PIM-PROTAC". The 3-year grant, running from March 1, 2025 to February 29, 2028, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The funding will...
The University of Arizona was awarded a $2.456 million Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to identify the role of the rostral ventromedial medulla in mediating postoperative thermal and mechanical hypersensitivity reduction after green light exposure. As the prime grantee, the University of Arizona will conduct the scientific...
This $306,971 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research into the "Neurovascular Mechanisms of Depression and Implications in Cardiovascular Health" at the University of Arizona. The 2-year grant, which commenced on April 1, 2024, funds basic and applied research activities by the University to investigate the relationships between neurological, vascular, and psychological...
The University of Arizona, through the Arizona Board of Regents, was awarded a $3,004,651 Project Grant from the Defense Health Agency to develop a treatment for neuropsychological and memory impairments following moderate to severe traumatic brain injury. This grant, awarded under the Military Medical Research and Development (CFDA 12.420) program, funds a research project aimed at advancing scientific understanding and improving patient care for service members and veterans affected by...
This Project Grant award of $3,069,903.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at the University of Arizona to investigate the effectiveness of transcranial magnetic stimulation of the default mode network to improve sleep. The award commenced on September 1, 2024 and is scheduled for completion on August 31, 2027. The research aims to transform healthcare for military service members, veterans, and the broader...
The University of Arizona received a $2,997,638 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2022 through September 2025 to regulate mood and suicidal ideation through morning light exposure treatment for individuals with traumatic brain injury. The Military Medical Research and Development program supports basic, applied, and advanced...
This $1,195,956 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development and translation of a virtual reality-based military operational neuropsychological assessment tool. The funding will enable the University of Arizona, as the prime awardee, to create and validate a model for this innovative virtual reality assessment system. The anticipated completion date for this 3-year effort is September 29,...
This Project Grant award of $1,275,092.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Arizona State University (ASU). The grant supports research to understand how individual, organizational, and disclosure factors predict psychological distress in male and female survivors of military sexual assault. ASU has subcontracted a portion of the work to the University of California, Irvine (UCI) to contribute their expertise in...
The Department of the Army Medical Command awarded a $2,008,900 project grant to the Veterans Medical Research Foundation of San Diego under the Military Medical Research and Development program (CFDA 12.420). The four-year project grant will fund research into combined nonpharmacological therapies for mild traumatic brain injury (mTBI)-related headaches from September 2021 through August 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...

This $300,378 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research at the University of Arizona to identify a male-specific mechanism of nociceptor sensitization that promotes migraine in active-duty service members and veterans. The research aims to develop new treatments, diagnostic tools, and clinical practice guidelines to improve the health and care of military personnel and their families. As an academic research institution with extensive expertise across biomedical disciplines, the University of Arizona will conduct basic, translational, and clinical research over the 2-year period from February 2024 to January 2026 to advance innovative solutions in military medicine. This project aligns with the Military Medical Research and Development program's emphasis on funding high-impact research with potential for significant clinical impact.

Generated 10/29/24, 5:25 AM